Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STORM-PE: Anticoagulation vs Anticoagulation + Indigo Aspiration System for Acute PE
NCT05684796Completed
- Sponsor
- Penumbra
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Countries
- 4
01
Overview
Randomised, open-label trial in pulmonary embolism (PE) (2 arms), sponsored by Penumbra. Primary endpoint: Change in Right Ventricular to Left Ventricular Ratio at 48 hours. Started Nov 2023; status: completed.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT05684796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684796.